PHEX: A Potential Drug Target for Pancreatic Cancer (G5251)

Target Name: PHEX

NCBI ID: G5251

PHEX

PHEX: A Potential Drug Target for Pancreatic Cancer

PHEX, short for Pancreatic cancer associated protein-expression, is a protein that is expressed in high levels in pancreatic cancer cells. It has been identified as a potential drug target or biomarker for pancreatic cancer, and research is being conducted to investigate its effectiveness in treating this aggressive form of cancer.

Pancreatic cancer is a relatively rare type of cancer that affects the pancreas, a gland located behind the stomach that produces hormones and digestive enzymes. pancreatic cancer is often treated as a result of its poor prognosis and high mortality rate, with a five-year survival rate of only around 10%. Despite this, pancreatic cancer is the most common cause of cancer-related deaths in the United States.

One of the major challenges in the treatment of pancreatic cancer is the lack of effective therapies that can target the cancer cells specifically. Many existing treatments for pancreatic cancer are designed to target all types of cancer cells, rather than targeting the specific characteristics that make the cancer cells so dangerous. This has led to a lack of effective treatment options for pancreatic cancer patients.

PHEX is a protein that is expressed in high levels in pancreatic cancer cells. It has been shown to be involved in a variety of cellular processes that are important for cancer cell growth and survival. For example, PHEX has been shown to be involved in cell signaling pathways that promote the growth and survival of cancer cells. It has also been shown to play a role in the development of pancreatic cancer stem cells, which are able to differentiate into different types of cancer cells and contribute to the development of new tumors.

In addition to its role in cancer cell growth and survival, PHEX has also been shown to be involved in the regulation of cellular processes that are important for normal cell function. For example, PHEX has been shown to be involved in the production of digestive enzymes , which are essential for the digestion of food. It has also been shown to be involved in the production of insulin, a hormone that helps regulate blood sugar levels.

Based on the expression of PHEX in pancreatic cancer, researchers are exploring its use as a potential drug target or biomarker to treat pancreatic cancer. By specifically expressing PHEX in tumor cells, the growth and spread of tumor cells can be inhibited, thereby improving the therapeutic effect.

In addition, PHEX can also serve as a potential drug target for the treatment of other types of cancer. Since PHEX is expressed in many types of cancer, it can be used as a universal drug target to treat many types of cancer.

Although PHEX is a promising drug target or biomarker, current research on PHEX is still in its preliminary stages. More research will be needed to fully understand its role in pancreatic cancer and its potential as a treatment.

Protein Name: Phosphate Regulating Endopeptidase X-linked

Functions: Peptidase that cleaves SIBLING (small integrin-binding ligand, N-linked glycoprotein)-derived ASARM peptides, thus regulating their biological activity (PubMed:9593714, PubMed:15664000, PubMed:18162525, PubMed:18597632). Cleaves ASARM peptides between Ser and Glu or Asp residues (PubMed:18597632). Regulates osteogenic cell differentiation and bone mineralization through the cleavage of the MEPE-derived ASARM peptide (PubMed:18597632). Promotes dentin mineralization and renal phosphate reabsorption by cleaving DMP1- and MEPE-derived ASARM peptides (PubMed:18597632, PubMed:18162525). Inhibits the cleavage of MEPE by CTSB/cathepsin B thus preventing MEPE degradation (PubMed:12220505)

The "PHEX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PHEX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets